Emmprin and KSHV: New partners in viral cancer pathogenesis

Biswas, 1995, The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily, Cancer Res., 55, 434 Ellis, 1989, Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor, Cancer Res., 49, 3385 Yan, 2005, Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression, Thromb. Haemost., 93, 199, 10.1160/TH04-08-0536 Nabeshima, 2006, Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression, Pathol. Int., 56, 359, 10.1111/j.1440-1827.2006.01972.x Iacono, 2007, CD147 immunoglobulin superfamily receptor function and role in pathology, Exp. Mol. Pathol., 83, 283, 10.1016/j.yexmp.2007.08.014 Toole, 2008, Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance, Drug Resist. Updat., 11, 110, 10.1016/j.drup.2008.04.002 Weidle, 2010, Cancer-related issues of CD147, Cancer Genomics Proteomics, 7, 157 Hao, 2010, CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer, Curr. Cancer Drug Targets, 10, 287, 10.2174/156800910791190193 Kennedy, 2010, Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation, Future Oncol., 6, 127, 10.2217/fon.09.145 Toole, 2008, Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells, Semin. Cancer Biol., 18, 244, 10.1016/j.semcancer.2008.03.009 Pushkarsky, 2001, CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A, Proc. Natl. Acad. Sci. USA, 98, 6360, 10.1073/pnas.111583198 Watanabe, 2010, CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells, J. Virol., 84, 4183, 10.1128/JVI.02168-09 Chen, 2005, Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus, J. Infect. Dis., 191, 755, 10.1086/427811 Tian, 2010, Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection, J. Virol., 84, 3373, 10.1128/JVI.02555-09 Feng, 2011, Hepatitis C virus core protein promotes the migration and invasion of hepatocyte via activating transcription of extracellular matrix metalloproteinase inducer, Virus Res., 158, 146, 10.1016/j.virusres.2011.03.025 Shackel, 2002, Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression, Am. J. Pathol., 160, 641, 10.1016/S0002-9440(10)64884-5 Chang, 1994, Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma, Science, 266, 1865, 10.1126/science.7997879 Cesarman, 1995, Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas, N. Engl. J. Med., 332, 1186, 10.1056/NEJM199505043321802 Mesri, 2010, Kaposi’s sarcoma and its associated herpesvirus, Nat. Rev. Cancer, 10, 707, 10.1038/nrc2888 Vanni, 2006, Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives, Cancer Treat. Rev., 32, 445, 10.1016/j.ctrv.2006.06.001 Von Roenn, 2003, Clinical presentations and standard therapy of AIDS-associated Kaposi’s sarcoma, Hematol. Oncol. Clin. North Am., 17, 747, 10.1016/S0889-8588(03)00043-1 Nguyen, 2008, Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response, AIDS, 22, 937, 10.1097/QAD.0b013e3282ff6275 Qin, 2011, Regulation of Nm23-H1 and cell invasiveness by Kaposi’s sarcoma-associated herpesvirus, J. Virol., 85, 3596, 10.1128/JVI.01596-10 Qian, 2007, Kaposi’s sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases, J. Virol., 81, 7001, 10.1128/JVI.00016-07 Sun, 2006, Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation, Oncogene, 25, 2717, 10.1038/sj.onc.1209298 Montaner, 2004, The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia, Blood, 104, 2903, 10.1182/blood-2003-12-4436 Pati, 2001, Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi’s sarcoma pathogenesis, J. Virol., 75, 8660, 10.1128/JVI.75.18.8660-8673.2001 Sharma-Walia, 2010, Kaposi’s sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion, PLoS Pathog., 6, e1000777, 10.1371/journal.ppat.1000777 DiMaio, 2011, Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes, PLoS Pathog., 7, e1002424, 10.1371/journal.ppat.1002424 Sadagopan, 2009, Kaposi’s sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis, J. Virol., 83, 3342, 10.1128/JVI.02052-08 Qin, 2010, Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus, Cancer Res., 70, 3884, 10.1158/0008-5472.CAN-09-4663 Dai, 2012, KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction, Int. J. Cancer, 131, 834, 10.1002/ijc.26428 Dai, 2012, Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts, Cancer Lett., 318, 214, 10.1016/j.canlet.2011.12.019 Crawford, 2009, PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment, Cancer Cell, 15, 21, 10.1016/j.ccr.2008.12.004 Gill, 2002, Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma–associated herpesvirus infection in patients with and without Kaposi sarcoma, J. Acquir. Immune Defic. Syndr., 31, 384, 10.1097/00126334-200212010-00003 Miller, 2006, High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy, J. Clin. Microbiol., 44, 2409, 10.1128/JCM.00256-06 Casper, 2004, HIV infection and human herpesvirus-8 oral shedding among men who have sex with men, J. Acquir. Immune Defic. Syndr., 35, 233, 10.1097/00126334-200403010-00003 Campbell, 2000, Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi’s sarcoma clinical stage, AIDS, 14, 2109, 10.1097/00002030-200009290-00006 Rohrmus, 2000, Outlook in oral and cutaneous Kaposi’s sarcoma, Lancet, 356, 2160, 10.1016/S0140-6736(00)03503-0 Gorsky, 2000, A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi’s sarcoma, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 90, 612, 10.1067/moe.2000.109518 Sharma-Walia, 2006, Cyclooxygenase 2 induced by Kaposi’s sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression, J. Virol., 80, 6534, 10.1128/JVI.00231-06 George Paul, 2010, Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi’s sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen, Cancer Res., 70, 3697, 10.1158/0008-5472.CAN-09-3934 Lee, 2011, Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases, Mol. Cell. Endocrinol., 332, 306, 10.1016/j.mce.2010.11.022 Kerur, 2010, Characterization of entry and infection of monocytic THP-1 cells by Kaposi’s sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling, Virology, 406, 103, 10.1016/j.virol.2010.07.012 Veettil, 2008, J. Virol., 82, 12126, 10.1128/JVI.01146-08 Garrigues, 2008, Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi’s sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor, J. Virol., 82, 1570, 10.1128/JVI.01673-07 Sharma-Walia, 2004, Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements, J. Virol., 78, 4207, 10.1128/JVI.78.8.4207-4223.2004 Akula, 2002, Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells, Cell, 108, 407, 10.1016/S0092-8674(02)00628-1 Zhao, 2011, HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells, Hepatology, 54, 2012, 10.1002/hep.24592 Dai, 2009, The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells, BMC Cancer, 9, 337, 10.1186/1471-2407-9-337 Tang, 2008, Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways, Cell. Mol. Life Sci., 65, 2933, 10.1007/s00018-008-8315-8 Berditchevski, 1997, Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6, J. Biol. Chem., 272, 29174, 10.1074/jbc.272.46.29174 Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat. Med., 13, 952, 10.1038/nm1613 Gasperini, 2012, Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling, Cancer Res., 72, 1157, 10.1158/0008-5472.CAN-11-3067 Cheng, 2011, KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition, Cell Host Microbe, 10, 577, 10.1016/j.chom.2011.10.011 Ullmann, 2008, GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions, Mol. Hum. Reprod., 14, 169, 10.1093/molehr/gan001 Wu, 2011, HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-beta signaling and is transcriptionally regulated by Slug, Oncogene, 30, 4410, 10.1038/onc.2011.149 Wang, 2011, Notch1 is involved in migration and invasion of human breast cancer cells, Oncol. Rep., 26, 1295 Grass, 2012, Regulation of invadopodia formation and activity by CD147, J. Cell Sci., 125, 777, 10.1242/jcs.097956 Chen, 2007, Primary effusion lymphoma, Oncologist, 12, 569, 10.1634/theoncologist.12-5-569 Simonelli, 2003, Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study, J. Clin. Oncol., 21, 3948, 10.1200/JCO.2003.06.013 Boulanger, 2005, Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS, J. Clin. Oncol., 23, 4372, 10.1200/JCO.2005.07.084 Petre, 2007, Functional p53 signaling in Kaposi’s sarcoma-associated herpesvirus lymphomas: implications for therapy, J. Virol., 81, 1912, 10.1128/JVI.01757-06 Munoz-Fontela, 2008, Induction of paclitaxel resistance by the Kaposi’s sarcoma-associated herpesvirus latent protein LANA2, J. Virol., 82, 1518, 10.1128/JVI.01704-07 Qin, 2011, Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma, Leukemia, 25, 1598, 10.1038/leu.2011.144 Toole, 2009, Hyaluronan-CD44 Interactions in cancer: paradoxes and possibilities, Clin. Cancer Res., 15, 7462, 10.1158/1078-0432.CCR-09-0479 Zoller, 2011, CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?, Nat. Rev. Cancer, 11, 254, 10.1038/nrc3023 Boshoff, 1998, Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice, Blood, 91, 1671, 10.1182/blood.V91.5.1671.1671_1671_1679 Slomiany, 2009, Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides, Clin. Cancer Res., 15, 7593, 10.1158/1078-0432.CCR-09-2317 Dai, 2013, CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells, Am. J. Pathol., 182, 577, 10.1016/j.ajpath.2012.10.011 Kirk, 2000, CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression, EMBO J., 19, 3896, 10.1093/emboj/19.15.3896 Philp, 2003, Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse, Invest. Ophthalmol. Vis. Sci., 44, 1305, 10.1167/iovs.02-0552 Wilson, 2005, Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70), J. Biol. Chem., 280, 27213, 10.1074/jbc.M411950200 Slomiany, 2009, Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells, Cancer Res., 69, 1293, 10.1158/0008-5472.CAN-08-2491 Warburg, 1956, On respiratory impairment in cancer cells, Science, 124, 269, 10.1126/science.124.3215.269 Gatenby, 2004, Why do cancers have high aerobic glycolysis?, Nat. Rev. Cancer, 4, 891, 10.1038/nrc1478 Koukourakis, 2006, Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis, Cancer Sci., 97, 1056, 10.1111/j.1349-7006.2006.00298.x Pelicano, 2006, Glycolysis inhibition for anticancer treatment, Oncogene, 25, 4633, 10.1038/sj.onc.1209597 Bhatt, 2012, Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma, Proc. Natl. Acad. Sci. USA, 109, 11818, 10.1073/pnas.1205995109 Delgado, 2010, Induction of the Warburg effect by Kaposi’s sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells, Proc. Natl. Acad. Sci. USA, 107, 10696, 10.1073/pnas.1004882107 Carroll, 2004, Kaposi’s sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation, Virology, 328, 7, 10.1016/j.virol.2004.07.008 An, 2006, Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi’s sarcoma-associated herpesvirus latency in vitro and in vivo, J. Virol., 80, 4833, 10.1128/JVI.80.10.4833-4846.2006 Pyakurel, 2006, Lymphatic and vascular origin of Kaposi’s sarcoma spindle cells during tumor development, Int. J. Cancer, 119, 1262, 10.1002/ijc.21969 Renne, 2001, Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus, J. Virol., 75, 458, 10.1128/JVI.75.1.458-468.2001 Lan, 2004, Kaposi’s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency, J. Virol., 78, 6585, 10.1128/JVI.78.12.6585-6594.2004 Verma, 2004, Latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1, J. Virol., 78, 10348, 10.1128/JVI.78.19.10348-10359.2004 Chen, 2010, Distinct p53, p53:LANA, and LANA complexes in Kaposi’s Sarcoma–associated Herpesvirus Lymphomas, J. Virol., 84, 3898, 10.1128/JVI.01321-09 Liang, 2002, Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN), Gene, 282, 75, 10.1016/S0378-1119(01)00847-2 Hagemann, 2005, Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK, J. Immunol., 175, 1197, 10.4049/jimmunol.175.2.1197 Matta, 2004, Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP), Proc. Natl. Acad. Sci. USA, 101, 9399, 10.1073/pnas.0308016101 Chugh, 2005, Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice, Proc. Natl. Acad. Sci. USA, 102, 12885, 10.1073/pnas.0408577102 Cannon, 2003, The Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells, J. Virol., 77, 57, 10.1128/JVI.77.1.57-67.2003 Cannon, 2007, The KSHV and other human herpesviral G protein-coupled receptors, Curr. Top. Microbiol. Immunol., 312, 137, 10.1007/978-3-540-34344-8_5 Menashi, 2003, Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells, Cancer Res., 63, 7575 Shi, 2001, Change in gene expression subsequent to induction of Pnn/DRS/memA: increase in p21(cip1/waf1), Oncogene, 20, 4007, 10.1038/sj.onc.1204507 Tang, 2004, Links between CD147 function, glycosylation, and caveolin-1, Mol. Biol. Cell, 15, 4043, 10.1091/mbc.E04-05-0402 Lim, 1998, Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38, FEBS Lett., 441, 88, 10.1016/S0014-5793(98)01474-4 Marieb, 2004, Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production, Cancer Res., 64, 1229, 10.1158/0008-5472.CAN-03-2832 Misra, 2003, Regulation of multidrug resistance in cancer cells by hyaluronan, J. Biol. Chem., 278, 25285, 10.1074/jbc.C300173200 Ghatak, 2005, Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells, J. Biol. Chem., 280, 8875, 10.1074/jbc.M410882200